Serious Adverse Events Reporting in Phase III Randomized Clinical Trials of Colorectal Cancer Treatments: A Systematic Analysis

Objective: The occurrence, development, and prognosis of serious adverse events (SAEs) associated with anticancer drugs in clinical trials have important guiding significance for real-world clinical applications. However, to date, there have been no studies investigating SAEs reporting in randomized...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yanhong Yao, Zhentao Liu, Hua Zhang, Jian Li, Zhi Peng, Jinyu Yu, Baoshan Cao, Lin Shen
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/60490e93b73749b4ba110cadce8e58ba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!